Open Source Medicine Foundation

Research Tracker

Daily automated feed of peer-reviewed studies and clinical trials on post-viral and chronic complex conditions.

🦠
Treatment synthesis

Post-Viral Illness

Curated, reference-backed treatment options for Long COVID, post-viral ME/CFS, post-dengue, post-polio, chikungunya, post-Ebola, post-infectious POTS, PANS/PANDAS, and post-Zika GBS.

🗂️
Cohort database

PAIS Cohorts

Design-verified catalogue of post-acute infection syndrome cohorts (not patients): denominator, controls, timepoints, and banked specimens made machine-readable, with gap matrices exposing where no adequate study exists.

🧪
Clinical Trials Tracker

Interventional Studies

Actively recruiting and recently completed clinical trials for PACVS, Long COVID, ME/CFS, and related conditions.

💊
Therapeutic Agents Tracker

Aggregated Evidence

Cross-condition synthesis of therapeutic agents being studied, with evidence levels and linked trial data.

🧠
RepurpOS

Alterations, Drugs & Natural Products

98-condition database (100-disease cure-vs-chronic list) of biomarkers, ranked therapeutics, natural products, and clinical trial evidence from Open Targets, HPO, ChEMBL, DGIdb, and OSMF reviews.

🗺️
Access & policy

Medical Freedom Maps

Static, search-indexable HTML — no Vercel/Render app required. Compare procedure access pathways across jurisdictions and healthcare laws across all 50 US states (right to try, scope of practice, telehealth, regenerative medicine, and more).

🧬
Biomarker Atlases

Condition-Specific Biomarkers

Peer-reviewed biomarker databases for Long COVID, PACVS, ME/CFS, Lyme disease, and Gulf War Illness. Searchable blood test alterations, cytokine panels, metabolites, and CSF markers with DOI citations.

💊
Investigational Therapeutics

Candidate Therapeutic Agents

Evidence-based review of investigational therapeutic agents for Long COVID, PACVS, ME/CFS, POTS, and MCAS. Filterable by condition, mechanism, and evidence tier with clinical trial data and mechanistic rationale.

🧬
Peptide Therapeutics

PeptideOS

Disinterested evidence on therapeutic peptides: efficacy tiers, regulatory status, purity data. Class A (approved) through Class C (gray market). No dosing advice, no vendors, funded by grants only.

🌍
Neglected Tropical Diseases

NTD Intelligence

The 21 WHO neglected tropical disease groups — burden, top therapeutic hits, and documented post-infectious syndromes with literature persistence rates (dengue, chikungunya, Chagas, leishmaniasis, and more).

Explore the research tracker

Everything below is generated from the same open data and refreshed with the daily update.

Match my lab resultsEnter which markers are high or low and see which conditions report the same direction in peer-reviewed studies. Biomarker pagesOne page per marker and condition: direction, comparison group, symptoms, LOINC code, source DOI and FAQ. Condition comparisonsLong COVID vs ME/CFS, PACVS vs Lyme and more: shared and distinct biomarkers, trials and therapeutics side by side. Recruiting clinical trialsOpen trials by condition and by agent, with registry links. Plus an interactive trial finder. Drug repurposing explorerCandidate agents per condition ranked by a transparent evidence score, linked to trials and literature. Agent × disease evidence pages"Does X help Y?" answered from registered trials and published studies, one page per pair. Weekly research digestNew studies and trial activity every week, with an RSS feed and archive. State of the evidence reportsAnnual, fully computed summaries per condition with methods and downloadable data. Embed the latest researchPaste a widget showing the newest studies for any condition on your own site.

Cite this page

Reusing these data? Please cite the tracker so others can find the source.

Open Source Medicine Foundation. (2026). Post-Viral Research Tracker. Research Tracker. https://research.opensourcemed.info/ (accessed )

Weekly post-viral research digest

New peer-reviewed studies and trial activity across Long COVID, ME/CFS, PACVS, Lyme and Gulf War Illness, every week. Free, no spam.

Subscribe on Substack   Browse the digest archive · RSS